Sight Sciences Inc. (SGHT)
| Bid | 2.47 |
| Market Cap | 130.9M |
| Revenue (ttm) | 81.61M |
| Net Income (ttm) | -52.63M |
| EPS (ttm) | -1.05 |
| PE Ratio (ttm) | -2.43 |
| Forward PE | -4.31 |
| Analyst | Hold |
| Ask | 2.96 |
| Volume | 62,804 |
| Avg. Volume (20D) | 264,005 |
| Open | 2.70 |
| Previous Close | 2.74 |
| Day's Range | 2.54 - 2.73 |
| 52-Week Range | 2.17 - 8.45 |
| Beta | 2.51 |
About SGHT
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthal...
Analyst Forecast
According to 7 analyst ratings, the average rating for SGHT stock is "Hold." The 12-month stock price forecast is $3.75, which is an increase of 47.06% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago · seekingalpha.com
Sight Sciences, Inc. (SGHT) Q4 2024 Earnings Conference Call TranscriptSight Sciences, Inc. (NASDAQ:SGHT ) Q4 2024 Earnings Conference Call March 5, 2025 4:30 PM ET Company Participants Philip Trip Taylor - IR Paul Badawi - Co-Founder & CEO Alison Bauerlein - CFO Matt Li...
